We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Adalimumab

Australian Public Assessment Report

AusPAR

AusPAR: Adalimumab [PDF, 992.51 KB]

AusPAR: Adalimumab [DOCX, 1.13 MB]

Attachment: Product Information: Adalimumab [PDF, 954.21 KB]

Attachment: Product Information: Adalimumab [DOCX, 689.85 KB]

Attachment: Extract from Clinical Evaluation Report: Adalimumab [PDF, 2.83 MB]

Attachment: Extract from Clinical Evaluation Report: Adalimumab [DOCX, 5.76 MB]

Device/Product Name

Amgevita

Active ingredients

Adalimumab

AusPAR Date

25 June 2018

Published

16 July 2018

Submission Number

PM-2016-00845-1-1

Submission Type

Biosimilar medicine

Decision

Approved

Product types

Prescription medicines